| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
35,948 |
31,781 |
$3.77M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32,731 |
28,593 |
$2.28M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
5,108 |
4,932 |
$636K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,189 |
5,184 |
$446K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,155 |
5,153 |
$438K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,892 |
3,890 |
$365K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,074 |
3,851 |
$324K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
21,566 |
10,690 |
$312K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
8,190 |
7,814 |
$302K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
13,391 |
13,300 |
$298K |
| 99441 |
|
5,505 |
5,160 |
$259K |
| 92587 |
|
9,986 |
9,976 |
$229K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,855 |
4,643 |
$219K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
1,645 |
1,641 |
$181K |
| 99051 |
|
10,033 |
9,586 |
$167K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,325 |
3,171 |
$113K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,505 |
1,455 |
$111K |
| 99188 |
|
6,480 |
6,472 |
$90K |
| 99442 |
|
1,117 |
998 |
$86K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,907 |
1,792 |
$83K |
| 99215 |
Prolong outpt/office vis |
491 |
453 |
$66K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12,870 |
12,332 |
$53K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
429 |
429 |
$42K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,504 |
1,454 |
$37K |
| V2020 |
Frames, purchases |
824 |
819 |
$37K |
| 96116 |
|
619 |
618 |
$35K |
| 85018 |
|
16,869 |
16,824 |
$33K |
| V2100 |
Sphere, single vision, plano to plus or minus 4.00, per lens |
911 |
648 |
$33K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,567 |
3,536 |
$32K |
| 83655 |
|
2,410 |
2,396 |
$29K |
| 92015 |
Determination of refractive state |
2,103 |
2,100 |
$28K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
195 |
195 |
$20K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
206 |
200 |
$19K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
983 |
981 |
$19K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,881 |
1,881 |
$19K |
| 81000 |
|
4,809 |
4,704 |
$18K |
| 87807 |
|
1,413 |
1,362 |
$18K |
| H0049 |
Alcohol and/or drug screening |
1,383 |
1,383 |
$18K |
| 0001A |
|
441 |
437 |
$17K |
| 90677 |
|
192 |
192 |
$15K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
234 |
233 |
$15K |
| 0002A |
|
371 |
371 |
$14K |
| 99173 |
|
1,241 |
1,240 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
614 |
598 |
$12K |
| 92551 |
|
3,169 |
3,165 |
$11K |
| 86580 |
|
1,233 |
1,193 |
$11K |
| 87634 |
|
372 |
363 |
$9K |
| 94060 |
|
148 |
139 |
$7K |
| 81002 |
|
3,362 |
3,295 |
$7K |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
328 |
327 |
$6K |
| G0445 |
High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes |
289 |
289 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
44 |
44 |
$4K |
| 90651 |
|
343 |
343 |
$4K |
| 90619 |
|
58 |
58 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
1,189 |
1,187 |
$3K |
| 90658 |
|
1,859 |
1,854 |
$3K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
298 |
298 |
$3K |
| 90461 |
|
201 |
201 |
$3K |
| 99383 |
|
27 |
27 |
$3K |
| 87806 |
|
136 |
136 |
$3K |
| 90621 |
|
154 |
154 |
$2K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
12 |
12 |
$2K |
| 87631 |
|
77 |
77 |
$2K |
| 92567 |
|
138 |
134 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
13 |
$2K |
| 99000 |
|
8,456 |
7,875 |
$2K |
| 90670 |
|
916 |
915 |
$1K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
12 |
12 |
$1K |
| 99381 |
|
12 |
12 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
68 |
66 |
$797.47 |
| 90734 |
|
250 |
250 |
$793.82 |
| 93000 |
|
44 |
43 |
$644.37 |
| 81025 |
|
307 |
292 |
$640.40 |
| 69210 |
|
15 |
15 |
$616.43 |
| 90707 |
|
291 |
291 |
$539.46 |
| 90715 |
|
219 |
219 |
$507.64 |
| 96127 |
|
474 |
474 |
$494.47 |
| 90716 |
|
378 |
378 |
$444.94 |
| 96160 |
|
484 |
484 |
$418.42 |
| 90698 |
|
1,158 |
1,157 |
$413.31 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$281.32 |
| 96161 |
|
147 |
123 |
$277.54 |
| 90744 |
|
270 |
268 |
$241.66 |
| 90656 |
|
47 |
47 |
$220.88 |
| 94664 |
|
29 |
29 |
$195.23 |
| V2784 |
Lens, polycarbonate or equal, any index, per lens |
407 |
201 |
$174.02 |
| 90633 |
|
375 |
375 |
$63.57 |
| 90657 |
|
199 |
199 |
$21.00 |
| 94760 |
|
38 |
38 |
$2.90 |
| 99072 |
|
81 |
81 |
$0.00 |
| 90713 |
|
25 |
25 |
$0.00 |
| 90700 |
|
25 |
25 |
$0.00 |
| 36416 |
|
3,606 |
3,589 |
$0.00 |
| 90680 |
|
400 |
400 |
$0.00 |